Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
Trial details
- Registry ID
- NCT07221578
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety DisorderNCT07221578 | Vanda Pharmaceuticals | Phase 3 | Active not recruiting | 2026-12Estimated |
| Evaluating the Effects of VQW-765 vs. Placebo in Performance AnxietyNCT04800237 | Vanda Pharmaceuticals | Phase 2 | Completed | 2022-08-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |